Critical Limb Ischemia: Current Trends and Future Directions

Martin Teraa, Michael S Conte, Frans L Moll, Marianne C Verhaar, Martin Teraa, Michael S Conte, Frans L Moll, Marianne C Verhaar

No abstract available

Keywords: critical limb ischemia; peripheral artery disease; secondary prevention; severe limb ischemia.

References

    1. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–965.
    1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386.
    1. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–128.
    1. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934.
    1. Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197–1207.
    1. Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, Murad MH. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62:1642–1651.
    1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter‐society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67.
    1. Becker F, Robert‐Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G, Eckstein HH, De Rango P, Diehm N, Schmidli J, Teraa M, Moll FL, Dick F, Davies AH, Lepantalo M, Apelqvist J. Chapter I: definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011;42(suppl 2):S4–S12.
    1. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. One‐year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–1206.
    1. Caro J, Migliaccio‐Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long‐term follow‐up of a large database. BMC Cardiovasc Disord. 2005;5:14.
    1. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter‐based treatment of critical limb ischemia. J Vasc Surg. 2009;50:1462–1473.
    1. Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC. Quality of life in patients with no‐option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg. 2010;52:843–849.
    1. Barshes NR, Chambers JD, Cohen J, Belkin M. Cost‐effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012;56:1015–1024.
    1. Peters EJ, Childs MR, Wunderlich RP, Harkless LB, Armstrong DG, Lavery LA. Functional status of persons with diabetes‐related lower‐extremity amputations. Diabetes Care. 2001;24:1799–1804.
    1. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209–215.
    1. Makdisse M, Pereira AC, Brasil DP, Borges JL, Machado‐Coelho GL, Krieger JE, Nascimento Neto RM, Chagas AC. Prevalence and risk factors associated with peripheral arterial disease in the Hearts of Brazil Project. Arq Bras Cardiol. 2008;91:370–382.
    1. Eraso LH, Fukaya E, Mohler ER III, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014;21:704–711.
    1. Conte MS. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence‐based treatment for advanced limb ischemia. J Vasc Surg. 2010;51:69S–75S.
    1. Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders. Helv Chir Acta. 1954;21:499–533.
    1. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4:80–94.
    1. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–538.
    1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter‐Society Consensus (TASC). J Vasc Surg. 2000;31:S1–S296.
    1. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–751.
    1. Egorova NN, Guillerme S, Gelijns A, Morrissey N, Dayal R, McKinsey JF, Nowygrod R. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. J Vasc Surg. 2010;51:878–885.
    1. Al‐Omran M, Tu JV, Johnston KW, Mamdani MM, Kucey DS. Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population‐based study. J Vasc Surg. 2003;38:279–288.
    1. Nowygrod R, Egorova N, Greco G, Anderson P, Gelijns A, Moskowitz A, McKinsey J, Morrissey N, Kent KC. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg. 2006;43:205–216.
    1. Eskelinen E, Eskelinen A, Alback A, Lepantalo M. Major amputation incidence decreases both in non‐diabetic and in diabetic patients in Helsinki. Scand J Surg. 2006;95:185–189.
    1. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54–60.
    1. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996–2005. J Vasc Surg. 2009;49:910–917.
    1. Hong MS, Beck AW, Nelson PR. Emerging national trends in the management and outcomes of lower extremity peripheral arterial disease. Ann Vasc Surg. 2011;25:44–54.
    1. Jones WS, Patel MR, Dai D, Subherwal S, Stafford J, Calhoun S, Peterson ED. Temporal trends and geographic variation of lower‐extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000–2008. J Am Coll Cardiol. 2012;60:2230–2236.
    1. Benoit E, O'Donnell TF Jr, Kitsios GD, Iafrati MD. Improved amputation‐free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J Vasc Surg. 2012;55:781–789.
    1. Chung J, Modrall JG, Ahn C, Lavery LA, Valentine RJ. Multidisciplinary care improves amputation‐free survival in patients with chronic critical limb ischemia. J Vasc Surg. 2015;61:162–169.
    1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)—summary of recommendations. J Vasc Interv Radiol. 2006;17:1383–1397.
    1. Diehm N, Schmidli J, Setacci C, Ricco JB, de Donato G, Becker F, Robert‐Ebadi H, Cao P, Eckstein HH, De Rango P, Teraa M, Moll FL, Dick F, Davies AH, Lepantalo M, Apelqvist J. Chapter III: management of cardiovascular risk factors and medical therapy. Eur J Vasc Endovasc Surg. 2011;42(suppl 2):S33–S42.
    1. Schanzer A, Conte MS. Critical limb ischemia. Curr Treat Options Cardiovasc Med. 2010;12:214–229.
    1. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124:17–23.
    1. Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez‐Eronini AA, Hoffman E, Bhatt DL. Predictors of long‐term adherence to evidence‐based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry. Clin Cardiol. 2013;36:721–727.
    1. Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sorensen HT, Johnsen SP. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Eur J Vasc Endovasc Surg. 2008;35:51–58.
    1. van Hattum ES, Tangelder MJ, Huis in ‘t Veld MA, Lawson JA, Algra A, Moll FL. Medical treatment after peripheral bypass surgery over the past decade. Eur J Vasc Endovasc Surg. 2011;41:805–813.
    1. Hogh A, Lindholt JS, Nielsen H, Jensen LP, Johnsen SP. Secondary medical prevention after primary vascular surgery between 1996 to 2006: a shift towards more evidence‐based treatment. Eur J Prev Cardiol. 2013;20:763–770.
    1. Subherwal S, Patel MR, Kober L, Peterson ED, Jones WS, Gislason GH, Berger J, Torp‐Pedersen C, Fosbol EL. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower‐extremity peripheral artery disease, underuse remains. Circulation. 2012;126:1345–1354.
    1. Secondary prevention in survivors of myocardial infarction. Joint Recommendations by the International Society and Federation of Cardiology, Scientific Councils on Arteriosclerosis, Epidemiology and Prevention, and Rehabilitation. Br Med J (Clin Res Ed). 1981;282:894–896.
    1. Teraa M, Sprengers RW, Schutgens RE, Slaper‐Cortenbach IC, van der Graaf Y, Algra A, van der Tweel I, Doevendans PA, Mali WP, Moll FL, Verhaar MC. Effect of repetitive intra‐arterial infusion of bone marrow mononuclear cells in patients with no‐option limb ischemia: the randomized, double‐blind, placebo‐controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra‐arterial Supplementation (JUVENTAS) trial. Circulation. 2015;131:851–860.
    1. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR III, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163:884–892.
    1. Hirsch AT, Halverson SL, Treat‐Jacobson D, Hotvedt PS, Lunzer MM, Krook S, Rajala S, Hunninghake DB. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med. 2001;6:87–96.
    1. Hirsch AT, Criqui MH, Treat‐Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324.
    1. Phillips LS, Branch WT, Cook CB, Doyle JP, El‐Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–834.
    1. Dijkstra RF, Braspenning JC, Uiters E, van Ballegooie E, Grol RT. Perceived barriers to the implementation of diabetes guidelines in hospitals in The Netherlands. Neth J Med. 2000;56:80–85.
    1. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, Goto S, Rother J, Steg PG, Hirsch AT. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis. 2009;204:e86–e92.
    1. Hackam DG, Sultan NM, Criqui MH. Vascular protection in peripheral artery disease: systematic review and modelling study. Heart. 2009;95:1098–1102.
    1. Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, Conte MS. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39:1178–1185.
    1. Iida O, Soga Y, Kawasaki D, Hirano K, Yamaoka T, Suzuki K, Miyashita Y, Yokoi H, Takahara M, Uematsu M. Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg. 2012;44:425–431.
    1. Siracuse JJ, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC, Chaikof EL, Nedeau AE, Schermerhorn ML. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg. 2012;55:1001–1007.
    1. Aiello FA, Khan AA, Meltzer AJ, Gallagher KA, McKinsey JF, Schneider DB. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg. 2012;55:371–379.
    1. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo‐controlled trial of gene therapy in critical limb ischaemia. Lancet. 2011;377:1929–1937.
    1. Ko SH, Bandyk DF. Therapeutic angiogenesis for critical limb ischemia. Semin Vasc Surg. 2014;27:23–31.
    1. Peeters Weem SM, Teraa M, de Borst GJ, Verhaar MC, Moll FL. Bone marrow derived cell therapy in critical limb ischemia: a meta‐analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg. 2015;50:775–783.
    1. Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M, Morishita R, Annex BH. Results of a double‐blind, placebo‐controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008;118:58–65.
    1. Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC. Autologous bone marrow‐derived cell therapy in patients with critical limb ischemia: a meta‐analysis of randomized controlled clinical trials. Ann Surg. 2013;258:922–929.
    1. Gremmels H, Teraa M, Quax PH, den Ouden K, Fledderus JO, Verhaar MC. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls. Mol Ther. 2014;22:1960–1970.
    1. Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, Robert‐Ebadi H, Cao P, Eckstein HH, De Rango P, Diehm N, Schmidli J, Dick F, Davies AH, Lepantalo M, Apelqvist J. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42(suppl 2):S43–S59.
    1. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010;51:18S–31S.
    1. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg. 2010;51:52S–68S.
    1. Dosluoglu HH, Lall P, Harris LM, Dryjski ML. Long‐term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular‐first approach by vascular surgeons. J Vasc Surg. 2012;56:361–371.
    1. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb‐threatening ischemia. J Vasc Surg. 2008;47:101–108.
    1. Romiti M, Albers M, Brochado‐Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta‐analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975–981.
    1. Giles KA, Pomposelli FB, Spence TL, Hamdan AD, Blattman SB, Panossian H, Schermerhorn ML. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008;48:128–136.
    1. O'Brien‐Irr MS, Harris LM, Dosluoglu HH, Dryjski ML. Procedural trends in the treatment of peripheral arterial disease by insurer status in New York State. J Am Coll Surg. 2012;215:311–321.
    1. Stoner MC, Defreitas DJ, Manwaring MM, Carter JJ, Parker FM, Powell CS. Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg. 2008;48:1489–1496.
    1. Forbes JF, Adam DJ, Bell J, Fowkes FG, Gillespie I, Raab GM, Ruckley CV, Bradbury AW. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health‐related quality of life outcomes, resource utilization, and cost‐effectiveness analysis. J Vasc Surg. 2010;51:43S–51S.
    1. Goodney PP, Holman K, Henke PK, Travis LL, Dimick JB, Stukel TA, Fisher ES, Birkmeyer JD. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57:1471–1479, 1480.
    1. Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg. 2016;63:244–253.
    1. Nolan BW, De Martino RR, Stone DH, Schanzer A, Goodney PP, Walsh DW, Cronenwett JL. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg. 2011;54:730–735.
    1. Jones DW, Schanzer A, Zhao Y, MacKenzie TA, Nolan BW, Conte MS, Goodney PP. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc. 2013;2:e000345 doi: .
    1. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation‐free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–1471.
    1. Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, Conte MS. Validation of the PIII CLI risk score for the prediction of amputation‐free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg. 2009;50:769–775.
    1. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180–1190.
    1. Siracuse JJ, Huang ZS, Gill HL, Parrack I, Schneider DB, Connolly PH, Meltzer AJ. Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia. Vasc Health Risk Manag. 2014;10:367–374.
    1. Jones WS, Schmit KM, Vemulapalli S, Subherwal S, Patel MR, Hasselblad V, Heidenfelder BL, Chobot MM, Posey R, Wing L, Sanders GD, Dolor RJ. Treatment strategies for patients with peripheral artery disease. Comparative Effectiveness Review No. 118. (Prepared by the Duke Evidence‐based Practice Center under Contract No. 290‐2007‐10066‐I.) AHRQ Publication No. 13‐EHC090‐EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2013. Available at: . Accessed December 22, 2015.
    1. Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220–234.
    1. Zhan LX, Branco BC, Armstrong DG, Mills JL Sr. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015;61:939–944.
    1. Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009;302:2254–2256.
    1. Farber A, Rosenfield K, Menard M. The BEST‐CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol. 2014;17:221–224.
    1. Norgren L, Hiatt WR, Dormandy JA, Hirsch AT, Jaff MR, Diehm C, Baumgartner I, Belch JJ. The next 10 years in the management of peripheral artery disease: perspectives from the ‘PAD 2009’ Conference. Eur J Vasc Endovasc Surg. 2010;40:375–380.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera